Bioventus Inc. (BVS) earnings date
Mar 9, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 27% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 39 days, typically, give or take 13 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Mon, Nov 2, 2026 | after close | 37 | 8-K |
| Q2 FY2026 | Wed, Aug 5, 2026 | before open | 39 | 8-K |
| Q1 FY2026 | Wed, May 6, 2026 | before open | 39 | 8-K |
| Q4 FY2025 | Thu, Mar 5, 2026 | before open | 64 | 8-K |
| Q3 FY2025 | Tue, Nov 4, 2025 | before open | 38 | 8-K |
| Q2 FY2025 | Wed, Aug 6, 2025 | before open | 39 | 8-K |
| Q1 FY2025 | Tue, May 6, 2025 | before open | 38 | 8-K |
| Q4 FY2024 | Tue, Mar 11, 2025 | before open | 70 | 8-K |
What they guided beta
| Q3 FY2026 | "The reduction in long-term debt lowers future interest payments and borrowing costs with the improved financial metrics in the Company's credit agreement. *See below under “Use of Non-GAAP Financial Measures” for more details. 2026 Financial Guidance For the twelve months ending December 31, 2026, the Company is:" exhibit |
| Q3 FY2026 | "The webcast will be archived on the Company’s website at https://ir.bioventus.com/ and available for replay until November 1, 2027." exhibit |
| Q3 FY2026 | "Important factors that may cause actual results to differ materially from current expectations include, among other things: whether the objectives of the Company's strategic alternatives review process will be achieved; the terms, structure, timing, benefits and costs of any strategic transaction; whether any such transaction will be consummated at all; the risk that the strategic alternatives review process could have an adverse effect on the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with customers, suppliers, employees, stockholde" exhibit |
| Q2 FY2026 | "Company reaffirms revenue, Adjusted Diluted EPS* and cash from operations guidance for the full year 2026" exhibit |
| Q2 FY2026 | "The reduction in long-term debt lowers future interest payments and borrowing costs with the improved financial metrics in the Company's credit agreement. *See below under “Use of Non-GAAP Financial Measures” for more details. 2026 Financial Guidance Bioventus is reaffirming its 2026 Financial Guidance provided on May 6, 2026." exhibit |
| Q2 FY2026 | "For the twelve months ending December 31, 2026, the Company expects:" exhibit |
| Q2 FY2026 | "The webcast will be archived on the Company’s website at https://ir.bioventus.com/ and available for replay until August 4, 2027. *See below under “Use of Non-GAAP Financial Measures” for more details." exhibit |
| Q2 FY2026 | "Important factors that may cause actual results to differ materially from current expectations include, among other things: whether the objectives of the Company's strategic alternatives review process will be achieved; the terms, structure, timing, benefits and costs of any strategic transaction; whether any such transaction will be consummated at all; the risk that the strategic alternatives review process and its announcement could have an adverse effect on the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with customers, suppliers, " exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/BVS
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/BVS
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/BVS/"><img src="https://veritasdata.dev/embed/BVS.svg" alt="BVS earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/BVS/)
Script
<script async src="https://veritasdata.dev/embed/BVS.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/BVS"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.